Systematic review and meta-analysis reveal late-stage outcomes may estimate mortality in trials, suggesting critical implications for cancer screening.
Summary of the “primary” late-stage and “main” mortality outcome estimates in the 57 trials.
No takes yet. Share an insight, caveat, or question.
Rebolj et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: